The Lancet highlights the global burden of foot disease and amputation in diabetic patients

November 10, 2005

Every 30 seconds a lower limb is amputated somewhere in the world as a consequence of diabetes, states a review in this week's issue of The Lancet. Most of the content of this week's issue is devoted to diabetic foot disease, coinciding with World Diabetes Day today (Friday November 14, 2005), which is this year focusing on foot complications.

The world is facing an epidemic of type 2 diabetes and the incidence of type 1 diabetes is also increasing. The lifetime risk of a person with diabetes developing a foot ulcer could be as high as 25%. If left untreated patients with the condition may have to have their leg amputated. In one of three reviews in this week's issue Andrew Boulton (Manchester Royal Infirmary, UK and University of Miami, Florida, USA) and colleagues note that diabetic foot ulceration and amputations were estimated to cost US healthcare payers $10.9 billion in 2001. In the UK, the cost of diabetes-related foot complications is estimated to be £252 million. However, foot ulcers and amputation are preventable. Provision of foot-care services can be associated with a reduction in amputations and simple clinical tests can predict those at risk of ulceration, state the authors.

Professor Boulton comments: "Identification of the at-risk foot does not require any expensive equipment: a tuning fork, pin, tendon hammer, and a 10g monofilament should suffice."

In a comment to accompany the issue Vilma Urbancic-Rovan (University Medical Centre, Ljubljana, Slovenia) writes: "One of the basic messages for the patient should be to seek professional advice as soon as possible, to minimise the risk of toe or limb amputation. One of the basic messages for health-care professionals is to always examine the feet of patients with diabetes who are at risk."

Unfortunately, however, this simple advice is ignored in many countries. In an accompanying editorial The Lancet comments: "The worldwide prevalence of diabetes now exceeds 200 million, and is predicted to rise to more than 300 million in the next 20 years. Up to 15% of patients with diabetes have a foot ulcer at some stage, and over 1 million amputations for diabetes-related complications occur every year...It is high time for health-care planners and health-care professionals to turn their attention to a condition that is a source of major morbidity and mortality, and that often afflicts those who are least able to cope. Someone, somewhere, loses a leg because of diabetes every 30 s of every day. To reduce this burden of disability by even a small amount would represent a major advance."
-end-
Contact: Professor Andrew JM Boulton, Department of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, UK. T) 001 305 389 9543 / 07814 936236 ABoulton@med.miami.edu

Comment: Dr Vilma Urbancic - Rovan, University Medical Centre Department of Endocrinology, Diabetes and Metabolic Diseases, Zaloška 7, 1525 Ljubljana, Slovenia. T) +386/1 522 27 38 vilma.urbancic@kclj.si

The Lancet press office 0207 424 4949/4249 pressoffice@lancet.com

Notes to editors This week's print issue contains one personal account from a patient with diabetic foot disease in Iraq. There are four other personal accounts from people in Brazil, Moscow, Tanzania, and Barbados that will be published online at http://www.thelancet.com/collections/diabetic_foot

Lancet

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.